Is the price fair?
What LEGN's price assumes
Legend Biotech Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 13.3× revenue.
13.3
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 11.9
Price / book · as of 2025-Q3
- EV / sales
- 13.3
EV / sales
Details›
- Price / book2025-Q3
- 11.9
- EV / sales2025-Q3
- 13.3
- Market capitalisation
- $5.19B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.